Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease

Vinod Burade,1 Rishit Zalawadia,1 Alpesh Patel,1 Abayomi Ogundele2 1Sun Pharmaceutical Industries Limited, Vadodara, Gujarat, India; 2Sun Pharmaceutical Industries, Inc, Princeton, NJ, USACorrespondence: Abayomi OgundeleSun Pharmaceutical Industries, Inc, Princeton, NJ, USATel +1 (609) 720-5389Email...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Burade V, Zalawadia R, Patel A, Ogundele A
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Dove Medical Press 2020-09-01
Ráidu:	Clinical Ophthalmology
Fáttát:	cyclosporine a goblet cell density keratoconjunctivitis sicca preclinical tear production
Liŋkkat:	https://www.dovepress.com/preclinical-efficacy-comparison-of-cyclosporine-ophthalmic-solution-00-peer-reviewed-article-OPTH
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!